Real world impact of rifaximin-α use in hepatic encephalopathy patients with advanced liver disease or continued alcohol misuse: A post-hoc analysis of the IMPRESS study
Authors: M Hudson, P Di Maggio, R Cipelli, R Aspinall
Published: United European Gastroenterology Journal, 2017